Top Brand
Our Recommendation
532+ trust this
WHO GMP Certified
532+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
In Treatment of Sneezing and runny nose due to allergies Fexanto ER 40 Tablet provides relief from symptoms such as sneezing, itching, watery eyes, and runny nose. This will make it easier for you to go about your daily activities. It rarely has any serious side effects and you may only need to take it on days you have symptoms. If you are taking it to prevent getting symptoms you should use it regularly to get the most benefit. In Treatment of Allergic conditions Fexanto ER 40 Tablet is effective in treating allergic skin conditions with inflammation and itching such as hives. It reduces the redness, rash, pain, or itchiness caused by your skin?s reaction to an irritant or allergen that may be causing the symptoms. It thus improves your self-esteem and confidence as your appearance changes. You may only need to take Fexanto ER 40 Tablet on a day you have symptoms or on a regular basis when allergens are most prevalent. Consult with your doctor to get maximum benefits.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Fexanto ER 40 Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
Fexanto ER 40 Tablet belongs to a class of medicines called antihistamines. It blocks the release of a chemical called histamine, which is responsible for causing inflammation and its associated symptoms such as itching, redness, swelling, and irritation.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Fexanto ER 40 Tablet . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Fexanto ER 40 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Fexanto ER 40 Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby. Because of low milk levels and lack of sleepiness, use of Fexanto ER 40 Tablet would not be expected to cause any adverse effects in breastfed babies.
SAFE - Fexanto ER 40 Tablet does not usually affect your ability to drive. However, you should check that Fexanto ER 40 Tablet does not make you feel sleepy or dizzy before driving or operating machinery.
Caution Advised: Fexanto ER 40 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Fexanto ER 40 Tablet may be needed. Doctor consultation is advised. May cause excessive sleepiness in patients with end stage kidney disease.
Safe when prescribed by an expert: Fexanto ER 40 Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Fexanto ER 40 Tablet may not be needed in these patients. Doctor consultation is advised.
If a dose of Fexanto ER 40 Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Behind Rajpath Club, Kensville Road, Opp. Infostretch Building, Off S.G. Highway, Ahmedabad- 380059, Gujarat- India
Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 997-98
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 534-35
Medscape. Febuxostat (02 Apr. 2019)
Febuxostat. Wooburn Green, Buckinghamshire: A. Menarini Farmaceutica Internazionale SRL; 2008 (25 Jan. 2019)
Febuxostat. Deerfield, Illinois: Takeda Pharmaceuticals America, Inc.; 2009 (02 Apr. 2019)
Central Drugs Standard Control Organisation (CDSCO) (02 Apr. 2019)
Febuxostat (24 June 2023)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.